Evangelia Liakoni1, Patrick C Dolder2, Katharina Rentsch3, Matthias E Liechti1. 1. Division of Clinical Pharmacology and Toxicology, University Hospital Basel and University of Basel, Switzerland. 2. Division of Clinical Pharmacology and Toxicology, University Hospital Basel and University of Basel, Switzerland / Laboratory Medicine, University Hospital Basel and University of Basel, Switzerland. 3. Laboratory Medicine, University Hospital Basel and University of Basel, Switzerland.
Abstract
QUESTIONS UNDER STUDY: To describe acute toxicity of recreational drugs including novel psychoactive substances. METHODS: We included all cases presenting at the emergency department (ED) of the University Hospital of Basel, Switzerland, between October 2013 and September 2014 with acute toxicity due to self-reported recreational drug use or with symptoms/signs consistent with acute toxicity. Isolated ethanol intoxications were excluded. Intoxications were confirmed with immunoassays and liquid chromatography coupled with mass spectrometry (LC-MS/MS), which also detected novel psychoactive substances. RESULTS: Among the 47,767 attendances at the ED, 216 were directly related to acute toxicity of recreational drugs. The mean patient age was 31 years and 69% were male. Analytical drug confirmation was available in 180 cases. Most presentations were related to cocaine (36%), cannabis (31%), opioids (13%), 3,4-methylenedioxy-methamphetamine (MDMA, 9%), other amphetamines (7%), benzodiazepines (7%), and lysergic acid diethylamide (LSD, 5%). The substances most commonly detected analytically were cannabis (37%), cocaine (33%), opioids (29%), benzodiazepines (21%), and amphetamines including MDMA (13%). Notably, there were only two cases of novel psychoactive substances (2,5-dimethoxy-4-bromophenethylamine [2C-B] and pentylone). The most frequent symptoms were tachycardia (31%), anxiety (27%), nausea or vomiting (23%), and agitation (22%). Severe complications included myocardial infarction (2), psychosis (10), seizures (10), and 1 fatality. Most patients were discharged home (68%), 8% were admitted to intensive care and 9% were referred to psychiatric care. CONCLUSION: Medical problems related to illicit drugs mostly concerned cocaine and cannabis and mainly involved sympathomimetic toxicity and/or psychiatric disorders. ED presentations associated with novel psychoactive substances appeared to be relatively rare.
QUESTIONS UNDER STUDY: To describe acute toxicity of recreational drugs including novel psychoactive substances. METHODS: We included all cases presenting at the emergency department (ED) of the University Hospital of Basel, Switzerland, between October 2013 and September 2014 with acute toxicity due to self-reported recreational drug use or with symptoms/signs consistent with acute toxicity. Isolated ethanol intoxications were excluded. Intoxications were confirmed with immunoassays and liquid chromatography coupled with mass spectrometry (LC-MS/MS), which also detected novel psychoactive substances. RESULTS: Among the 47,767 attendances at the ED, 216 were directly related to acute toxicity of recreational drugs. The mean patient age was 31 years and 69% were male. Analytical drug confirmation was available in 180 cases. Most presentations were related to cocaine (36%), cannabis (31%), opioids (13%), 3,4-methylenedioxy-methamphetamine (MDMA, 9%), other amphetamines (7%), benzodiazepines (7%), and lysergic acid diethylamide (LSD, 5%). The substances most commonly detected analytically were cannabis (37%), cocaine (33%), opioids (29%), benzodiazepines (21%), and amphetamines including MDMA (13%). Notably, there were only two cases of novel psychoactive substances (2,5-dimethoxy-4-bromophenethylamine [2C-B] and pentylone). The most frequent symptoms were tachycardia (31%), anxiety (27%), nausea or vomiting (23%), and agitation (22%). Severe complications included myocardial infarction (2), psychosis (10), seizures (10), and 1 fatality. Most patients were discharged home (68%), 8% were admitted to intensive care and 9% were referred to psychiatric care. CONCLUSION: Medical problems related to illicit drugs mostly concerned cocaine and cannabis and mainly involved sympathomimetic toxicity and/or psychiatric disorders. ED presentations associated with novel psychoactive substances appeared to be relatively rare.
Authors: Andrea Bollom; Jasmine Austrie; William Hirsch; Judy Nee; Daniel Friedlander; Johanna Iturrino; Sarah Ballou; Anthony Lembo Journal: J Clin Gastroenterol Date: 2018-10 Impact factor: 3.062
Authors: Mehrak Javadi-Paydar; Jacques D Nguyen; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe Journal: Neuropharmacology Date: 2017-09-04 Impact factor: 5.250
Authors: Jose Orsini; Christa Blaak; Salil Rajayer; Vikash Gurung; Eric Tam; Joaquin Morante; Ben Shamian; Ryan Malik Journal: J Community Hosp Intern Med Perspect Date: 2016-09-07
Authors: Jose Orsini; Nanda Din; Ershad Elahi; Anthony Gomez; Salil Rajayer; Ryan Malik; Elie Jean Journal: J Community Hosp Intern Med Perspect Date: 2017-09-19
Authors: Jorge Soares; Vera Marisa Costa; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela Journal: Arch Toxicol Date: 2021-06-08 Impact factor: 5.153